Lung organoids Accueil Human and animal health In vitro/ex vivo testing Antiviral and antibody evaluation Lung organoids In vitro/ex vivo testing Antiviral and antibody evaluation Our models for Human and animal health In vitro/ex vivo cytotoxicity Cytotoxic activity - 2D cell Cytotoxic activity - 3D human tissue Cytotoxic activity - human organoid Hemolysis assay In vivo safety Maximum tolerated dose Pharmacokinetics In vitro/ex vivo testing Antiviral and antibody evaluation 3D tissue Lung organoids Microneutralization assay Selective index - CC50 / IC50 assay Virological methodology Antibacterial and antifungal 3D tissue Anti-biofilm activity Antimicrobial susceptibility testing Antimicrobial synergy testing Bacterial genome editing Bacterial killing assay Bacterial susceptibility to bacteriophages Elisa Based assays Extracellular vesicles in pathophysiology Intracellular bacteria Lung organoids Mechanism of action - envelop integrity Minimum bactericidal concentration Minimum inhibitory concentration Persisters Resistance development Selective index - CC50 / IC50 assay Serum bactericidal assay Taylor-made ELISA Development Time kill Curve (TKC) Turbidity reduction assay In vivo Bacterial/fungal infection Gastrointestinal infection models Pulmonary infection models Septicemia models Skin infection models Thigh infection models Urinary tract infection models Viral infection Pulmonary infection models Septicemia models Inflammation DSS LPS Pulmonary fibrosis Download the case studies Lung organoids I accept GRPD conditions Download Quickly qualify your study needs Go !
